DOCSLIB.ORG

Literature Review and Assessment Report on MDMA / Ecstasy

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Literature Review and Assessment Report on MDMA / Ecstasy Literature Review and Assessment Report on MDMA / Ecstasy National Drug Policy Population Health Directorate Ministry of Health Wellington July 2009 Geoff Noller Contents EXECUTIVE SUMMARY ....................................................................................................................3 1.0 SUBSTANCE IDENTIFICATION, MECHANISM OF ACTION AND PRODUCTION...........................................................................................................5 1.1 CURRENT CLASSIFICATION ...........................................................................................7 2.0 OVERVIEW AND ANALYSIS OF INTERNATIONAL LITERATURE ON MDMA/ECSTASY .....................................................................................................7 2.1 HISTORY .......................................................................................................................7 2.1.1 Early Therapeutic Use..................................................................................................8 2.2 PATTERNS OF USE AND ABUSE.......................................................................................9 2.3 SPECIFIC EFFECTS / PHYSICAL HARMS ........................................................................10 2.3.1 Acute Effects...............................................................................................................11 2.3.1.1 Positive subjective effects...................................................................................................11 2.3.1.2 Less-severe physiological effects........................................................................................11 2.3.1.3 Serious acute effects............................................................................................................12 2.3.2 Long-term consequences of use..................................................................................15 2.3.2.1 Neurotoxicity ......................................................................................................................15 2.3.2.2 Animal studies and general critique ....................................................................................16 2.3.2.3 Psychopathology and cognitive deficits ..............................................................................17 2.4 RISKS TO PUBLIC HEALTH............................................................................................20 2.4.1 Availability and harms relative to population base....................................................20 2.4.2 Fatal toxicity compared with other drugs ..................................................................22 2.4.3 Seizure and production data.......................................................................................23 2.4.4 Purity and pricing ......................................................................................................23 2.4.5 Pill testing ..................................................................................................................24 2.4.6 Skewed media reporting and portrayal of drug use ...................................................25 2.4.7 Societal harms............................................................................................................26 2.4.7.1 Social harms comparison of MDMA with other drugs........................................................26 2.4.7.2 Public order.........................................................................................................................27 2.4.7.3 Drug facilitated sexual assault (DFSA)...............................................................................27 2.4.7.4 MDMA / ecstasy and drug policy .......................................................................................28 2.5 THERAPEUTIC VALUE ..................................................................................................30 2.5.1 Contemporary therapeutic research...........................................................................30 2.6 POTENTIAL FOR DEATH ...............................................................................................32 2.7 ABILITY TO CAUSE PHYSICAL AND PSYCHOLOGICAL DEPENDENCE .............................32 2.8 INTERNATIONAL CLASSIFICATION ...............................................................................35 2.8.1 United Nations’ drug control conventions .................................................................35 2.8.2 Other countries’ classification of MDMA ..................................................................35 3.0 RELEVANT NEW ZEALAND QUALITATIVE AND QUANTITATIVE RESEARCH ON MDMA/ECSTASY .....................................................................36 3.1 RESEARCH EXAMINING PREVALENCE OF MDMA / ECSTASY IN NEW ZEALAND..........36 3.2 ECSTASY-RELATED HARM IN NEW ZEALAND ..............................................................41 3.2.1 Physical and psychological health .............................................................................41 3.2.1.1 Dependence.........................................................................................................................44 3.2.2 Youth, social deviance, criminality, enforcement and economics ..............................46 3.2.2.1 Education ............................................................................................................................46 3.2.2.2 Driving................................................................................................................................47 3.2.2.3 Criminality ..........................................................................................................................49 3.2.2.4 Enforcement........................................................................................................................52 3.2.2.5 Economics...........................................................................................................................53 3.2.3 Policy..........................................................................................................................53 3.3 DISCUSSION ................................................................................................................59 3.4 RECOMMENDATIONS...................................................................................................60 4.0 INFORMATION CONCERNING MDMA/ECSTASY RELEVANT TO THE MISUSE OF DRUGS ACT (1975) SECTION 4B(2) .............................................61 1 4.1 GENERAL ....................................................................................................................61 4.2 DETAILED CRITERIA ...................................................................................................62 4.2.1 Likelihood or evidence of abuse.................................................................................62 4.2.2 Specific effects............................................................................................................63 4.2.3 Risks to public health .................................................................................................65 4.2.4 Therapeutic value.......................................................................................................66 4.2.5 Potential for use to cause death .................................................................................66 4.2.6 Ability for creation of physical or psychological dependence....................................67 4.2.7 International classification and experience of MDMA/Ecstasy in other jurisdictions... ....................................................................................................................................68 4.2.8 Other issues that the Minister may see fit to consider................................................69 REFERENCES ....................................................................................................................................70 APPENDICES ....................................................................................................................................87 APPENDIX I EXPERTS AND OTHER STAKEHOLDERS CONTACTED FOR COMMENT ON THE LITERATURE REVIEW OF MDMA / ECSTASY ....................................................................................88 APPENDIX II PROF. DOUGLAS SELLMAN: A BRIEF OVERVIEW OF PROPOSED ENTHEOGENIC RESEARCH ...................................................................................................................90 APPENDIX III MR. JOHN HORWOOD: OVERVIEW OF MDMA / ECSTASY-RELATED RESEARCH BY THE CHRISTCHURCH HEALTH AND DEVELOPMENT LONGITUDINAL STUDY (CHDS)..........92 APPENDIX IV COMMENT BY DR PHIL DALGARNO, RESEARCH LECTURER, DEPARTMENT OF PSYCHOLOGY, GLASGOW CALEDONIAN UNIVERSITY .................................................94 APPENDIX V PILL TESTING PROTOCOLS AND NEW ZEALAND EXAMPLE FROM: WWW.PILLREPORTS.COM.............................................................................................96 APPENDIX VI A DISCUSSION DOCUMENT PROVIDED BY MATT BOWDEN, STARGATE INTERNATIONAL FOUNDER, BACKGROUNDING PILL TESTING. ................................................................98 2 Executive Summary This paper reviews the international and New Zealand literature on the evidence on the risk of harm associated with 3,4, methylenedioxymethamphetamine [MDMA], an amphetamine-type stimulant (ATS). The information presented addresses the criteria which the Expert Advisory Committee on Drugs [EACD]
Load more

Recommended publications
  • Preventing Drug-Related Deaths at Music Festivals: Why the "Rave" Act Should Be Amended to Provide an Exception for Harm Reduction Services
    Chicago-Kent Law Review Volume 93 Issue 3 Comparative and Cross-Border Issues in Article 12 Bankruptcy and Insolvency Law 9-18-2018 Preventing Drug-Related Deaths at Music Festivals: Why the "Rave" Act Should be Amended to Provide an Exception for Harm Reduction Services Robin Mohr Chicago-Kent College of Law Follow this and additional works at: https://scholarship.kentlaw.iit.edu/cklawreview Part of the Criminal Law Commons, Entertainment, Arts, and Sports Law Commons, Food and Drug Law Commons, and the Legislation Commons Recommended Citation Robin Mohr, Preventing Drug-Related Deaths at Music Festivals: Why the "Rave" Act Should be Amended to Provide an Exception for Harm Reduction Services, 93 Chi.-Kent L. Rev. 943 (2018). Available at: https://scholarship.kentlaw.iit.edu/cklawreview/vol93/iss3/12 This Notes is brought to you for free and open access by Scholarly Commons @ IIT Chicago-Kent College of Law. It has been accepted for inclusion in Chicago-Kent Law Review by an authorized editor of Scholarly Commons @ IIT Chicago-Kent College of Law. For more information, please contact [email protected], [email protected]. PREVENTING DRUG-RELATED DEATHS AT MUSIC FESTIVALS: WHY THE “RAVE” ACT SHOULD BE AMENDED TO PROVIDE AN EXCEPTION FOR HARM REDUCTION SERVICES ROBIN MOHR INTRODUCTION Amid flashing lights and pulsing beats, nearly 100,000 electronic dance music fans attended Electric Zoo on New York’s Randall’s Island in August 2013.1 Unfortunately the party was cut short. Following the deaths of two young fans, the final day of the three-day music festival was can- celed at the request of city authorities.2 In separate incidents, Olivia Ro- tondo, a twenty-year-old University of New Hampshire student, and Jeffrey Russ, a twenty-three-year-old Syracuse University graduate,3 died after collapsing at Electric Zoo with high body temperatures.4 Toxicology results revealed that Ms.
    [Show full text]
  • Pathways to Drug Policies That Work
    TAKING CONTROL: PATHWAYS TO DRUG POLICIES THAT WORK SEPTEMBER 2014 Apu Comes/Folhapress GLOBAL COMMISSION ON DRUG POLICY MEMBERS Kofi Annan Aleksander Kwasniewski chairman of the Kofi Annan Foundation and former former President of Poland Secretary-General of the United Nations, Ghana Ricardo Lagos Louise Arbour former President of Chile former UN High Commissioner for Human Rights, Canada George Papandreou CONTENTS former Prime Minister of Greece Pavel Bém Foreword from THE CHAIR 04 former mayor of Prague, Czech Republic Jorge Sampaio former President of Portugal EXECUTIVE Summary 06 Richard Branson entrepreneur, advocate for social causes, founder of the George Shultz THE ‘WAR ON DRUGS’ HAS FAILED Virgin Group, cofounder of The Elders, United Kingdom former Secretary of State, United States – NEW approaches ARE EMERGING 10 (honorary chair) Fernando Henrique Cardoso KEY pathways to drug POLICIES that work 16 former President of Brazil (chair) Javier Solana former European Union High Representative for the 2.1 Put people’s health and safety first 18 Maria Cattaui Common Foreign and Security Policy, Spain 2.2 Ensure access to essential medicines and pain control 20 former Secretary-General of the International 2.3 End the criminalization and incarceration of people who use drugs 21 Chamber of Commerce, Switzerland Thorvald Stoltenberg 2.4 Refocus enforcement responses to drug trafficking and organized crime 23 former Minister of Foreign Affairs and UN High Ruth Dreifuss Commissioner for Refugees, Norway 2.5 Regulate drug markets to put governments in control 26 former Minister of Social Affairs and former President of Switzerland Mario Vargas Llosa GLOBAL LEADERSHIP FOR MORE EFFECTIVE AND HUMANE POLICIES 32 writer and public intellectual, Peru Cesar Gaviria References and Notes 37 former President of Colombia Paul Volcker former Chairman of the US Federal Reserve and of the Annex.
    [Show full text]
  • Program Book
    PROGRAM BOOK THE 8TH INTERNATIONAL CONFERENCE ON NIGHTLIFE, SUBSTANCE USE AND RELATED HEALTH ISSUES May 28-30, 2013 TABLE OF CONTENTS WELCOME 1 CONFERENCE SCHEDULE 2-6 PARALLEL SESSIONS 8-16 POSTERS 17 INFORMATION FOR ATTENDEES 18 WELCOME TO CLUB HEALTH SAN FRANCISCO 2013 WELCOME TO CLUB HEALTH SAN FRANCISCO 2013, THE 8TH INTERNATIONAL CONFERENCE ON NIGHTLIFE, SUBSTANCE USE AND RELATED HEALTH ISSUES. THIS EVENT MARKS ALMOST FIFTEEN YEARS OF INTERNATIONAL CLUB HEALTH CONFERENCES, AND THE FIRST TIME SUCH AN EVENT HAS HAPPENED IN THE AMERICAS. We’re EXCITED TO BRING EXPERTS FROM EUROPE, AUSTRALIA AND ASIA TOGETHER WITH THOSE FROM NORTH AND SOUTH AMERICA FOR THE FIRST TIME. We’re hosting Club Health in San Francisco not just because the city is known for its diverse and vibrant nightlife, but also because it is among the best in North America for implementing progressive, health-oriented nightlife policies that arise out of a process that keeps the whole community in mind. Our local partners – the San Francisco Public Health Department, the California Music and Culture Association and the San Francisco Entertainment Commission – are a sign of that commitment. The people in San Francisco have realized something that more cities across the United States, Canada and even Mexico and South America are starting to see: that a city’s nightlife powers its economic engine, and gives it a particular quality that makes it compelling to visit. Nightlife has value for its business and cultural aspects, but it also presents significant health and safety
    [Show full text]
  • Preloading and Post-Loading Among Ecstasy-Using Youth^
    Mediating MDMA-Related Harm: Preloading and Post-loading Among Ecstasy-Using Youth^ Brian C. Kelly, Ph.D.* Abstract—Ecstasy use remains a key concern for professionals working in fields related to youth and drug use. At the forefront of these concerns are issues related to neurological dysfunction and depression—both acute and long-term—associated with MDMA use. Ecstasy users have been shown • to assess Ecstasy related harms and to engage in a variety of practices to manage these risks. To contend with risk related to neurological dysfunction and depression, some youth have tumed to "preloading" and "post-loading": the practice of consuming other substances to mitigate the negative effects of Ecstasy. Drawing upon data from an ethnographic study of club drug use among youth, the author provides a descriptive profile of the practices of preloading and post-loading as well as the motivations underlying these behaviors among New York City area youth. Youth utilize a range of preloading and post-loading practices, yet do not universally share similar practices, attitudes, and knowledge. It is critical to link clinical and behavioral sciences research to further study both the efficacy and safety of these practices. Keywords—club drugs. Ecstasy, harm reduction, pre-loading, post-loading, youth With the global surge in Ecstasy use during recent de- between 1996 and 2001, with lifetime prevalence figures cades, and the potential for harm associated with the use of almost doubling (Johnston, O'Malley & Bachman 2002). Ecstasy, the continued study of the negative consequences U.S. national data suggests similar increases during that time related to Ecstasy use is critical.
    [Show full text]
  • Drug Criminalization Vs. Harm Reduction
    Running head: DRUG CRIMINALIZATION VS. HARM REDUCTION The Ideological Conflict between the Criminalization of Drug Use and Harm Reduction Programming Jessica Murray, M.A. Submitted in fulfillment of the requirements of Master of Arts in Criminology Faculty of Social Science and Humanities University of Ontario Institute of Technology Oshawa, Ontario February, 2019 DRUG CRIMINALIZATION VS. HARM REDUCTION Abstract Policies that criminalize individuals who use drugs were first enacted for the purpose of imposing deviant identities on impoverished and racialized communities. These policies, which are disproportionately enforced, have serious social, economic, and public health implications. Harm reduction philosophies seek to alleviate these consequences, but access to such programming is impeded by the stigma, enforcement, and professionalization of service provision associated with repressive drug policies. The failed War on Drugs is in opposition to harm reduction principles, thus exacerbating the harms of drug use in addition to generating unique harms of its own. In order to achieve justice for the drug using community, the mobilization of drug policy reform advocacy at all levels is necessary. In order to contextualize the stigma faced by individuals who use drugs, this report will illustrate the social construction of drug use as immoral and subsequent labelling of people who use drugs as deviant in an examination of the historical context of drug prohibitions and harm reduction philosophies. In highlighting the empirical evidence in support of harm reduction programming, I identify gaps in service provision and assess the ways in which prohibitory drug policies act as a barrier to service delivery, and in conclusion, provide recommendations for policy reform and means for achieving structural change.
    [Show full text]
  • Drug Policy Alliance Annual Report
    We’re leading the way together Drug Policy Alliance Annual Report Table of Contents 7 Ending Marijuana Prohibition 13 Ending the Drug War and Mass Incarceration 17 Promoting Health, Reducing Harm 23 Foundation Support 24 Advocacy Grants 25 Board and Honorary Board 26 Financial Statements The work described herein includes that of the Drug Policy Alliance, a 501(c)(3) organization, and Drug Policy Action, a 501(c)(4) organization. References to “DPA” refer to the work of both organizations. At DPA’s Reform Conference, asha bandele of DPA joined with activists Kemba Smith, who was granted clemency by President Clinton in 2000, and Jason Hernandez, the first Latino to receive clemency from President Obama. Both were convicted of nonviolent drug offenses – Smith was sentenced to 24.5 years behind bars, while Hernandez was sentenced to life in prison. Letter from the President and Executive Director Are You Ready to Make the Drug War History? Never before has the ground been more Making marijuana legal has always been a big fertile for a fundamental shift in our part of our work. Beginning with California in nation’s drug policies. 1996, DPA has played a pivotal role in roughly half of the campaigns that have legalized As a DPA member, you can be proud of the medical marijuana, most recently in New York. real change you’ve helped bring to fruition. As We’re also the only organization that played a result of our work, hundreds of thousands of a role in all the victorious campaigns to legalize people have been diverted from incarceration, marijuana more broadly – Colorado and millions of people can safely access marijuana Washington in 2012, Uruguay in 2013, without being considered criminals, and states and Oregon, Alaska and Washington, D.C., like California, Colorado, Connecticut, New in 2014.
    [Show full text]
  • Harm Reduction Victoria 128 Peel Street VIC 2051 Hrvic.Org.Au The
    LC LSIC Inquiry into Use of Cannabis in Victoria Submission 1385 Harm Reduction Victoria 128 Peel Street VIC 2051 HRVic.org.au The Secretary Legal and Social Services Committee Parliament House Spring Street EAST MELBOURNE VIC 3002 [email protected] 31 August 2020 Inquiry into the Use of Cannabis in Victoria Dear Secretary, Harm Reduction Victoria (HRVic) welcomes the opportunity to make this submission to the Legal and Social Services Committee for the Inquiry into the Use of Cannabis in Victoria. HRVic will comment on the following terms of reference, regarding ‘the best means to’: a) prevent young people and children from accessing and using cannabis in Victoria b) protect public health and public safety in relation to the use of cannabis in Victoria; c) implement health education campaigns and programs to ensure children and young people and aware of the dangers of drug use, in particular, cannabis use; d) prevent criminal activity relating to the legal cannabis trade in Victoria; 1 of 53 LC LSIC Inquiry into Use of Cannabis in Victoria Submission 1385 Table of contents Harm Reduction Victoria (HRVic) Background 22 HRVic Vision HRVic Mission Statement HRVic Guiding Principles Introduction and Key Considerations 5 Recomendations 99 Appendix I Attached as separate document Appendix II Available October 2020 1 2 of 53 LC LSIC Inquiry into Use of Cannabis in Victoria Submission 1385 Harm Reduction Victoria (HRVic) Background Harm Reduction Victoria (HRVic, formerly VIVAIDS Inc.) is the drug user organisation (DUO) for the state of Victoria and receives Department of Health and Human Services (DHHS) funding.
    [Show full text]
  • Mattersofsubstance
    Mattersof Substance. may 2014 Volume 25 Issue No.2 www.drugfoundation.org.nz Will they ever learn? What happens when a student turns up to class stoned? Do they get kicked out of school or do they get help and support? Which approach is better for the student, their peers and society? CONTENTS Will they WORLD 18 ever learn? NEWS Cover: ABOUT What happens to kids COVER 04 A DRUG who turn up to school stoned? STORY 06 NZ NEWS Q&A: 02 DARIEN FENTON FEATURE: There’s an app FOR THAT 40 30 $ FEATURES Become 20 26 30 34 a member CheckiT out oh, vienna! There’s an erowid et al A night out on the town A report back from the app for that Websites sharing drug The New Zealand Drug Foundation has with harm minimisation 57th Commission on Apps and technology are experiences are playing been at the heart of major alcohol and organisation ChEckiT!. Narcotic Drugs. helping people get into, an important role in other drug policy debates for over 20 years. and stay in, recovery. harm reduction. During that time, we have demonstrated a strong commitment to advocating policies and practices based on the best evidence available. You can help us. A key strength of the Drug REGULARS Foundation lies in its diverse membership base. As a member of the Drug Foundation, you will receive information about major The Director’s Cut 01 alcohol and other drug policy challenges. You can also get involved in our work to find Events 01 16 32 40 solutions to those challenges.
    [Show full text]
  • Recommendation of a Strategy
    Harm Reduction Strategies for Managing EDM Events J.C. Diaz 1st VP, International Nightlife Association Executive Director, Nightlife Foundation Overview EDM industry is huge and still growing The US is seriously behind on harm reduction and safety in favor of financial and legal security for festivals and events. Introduce Friendly Harm reduction strategies Medical, drug and mental health trained staff Certifying club owners and event managers Show how to Partner with law enforcement Long-term goals Training and Certifying Venues and Staff Educate the Public on Being Responsible Reduce Overexertion and Heat Exhaustion Eliminate Deaths at EDM related Events Eliminate Alcohol or Drug related Overdoses Support Amending the RAVE Act The Present Situation EDM is amazingly popular with 2.3 Billion Youtube VIEWS and 8.4 Million LIKES in 2014 Ages 25 & under, view the most online content Ages 25-34 has largest segment growth Ages 35-49 grew 80% from Jan to July 2014 EDM is a $6.2 Billion global industry: Festivals ($1.03b); Global club gigs ($2.4b); Las Vegas clubs ($800m); music sales ($800m); streaming/video services ($600m); DJ software & hardware sales ($360m); online platforms ($140m); other DJ Ventures ($60m). (Source: Youtube and Assoc. For Electronic Music) The Present Situation 32,000,000+ US people attend at least 1 festival Willing to travel 600 miles and spend avg $1000 Ages:18-24 represent 24%; 25-34 represent 22%; 35-49 represent 48%; 50+ group represents 15% Attendees: Coachella 579k; Austin City Limits 450k; EDClv 400k; Lollapalooza 325k, Ultra 165k Largest sponsors include PepsiCo, Coca-Cola, Anheuser-Busch, Heineken and Miller Coors 2 Drug-deaths at festivals vs.
    [Show full text]
  • The Psychedelic Renaissance
    The Psychedelic Renaissance Reassessing the Role of Psychedelic Drugs in 21st Century Psychiatry and Society Dr. Ben Sessa MBBS BSc MRCPsych First published by Muswell Hill Press, London, 2012 © 2012 Ben Sessa Ben Sessa has asserted his right under the Copyright, Design and Patents Act 1988 to be identified as the author of this work. All rights reserved. No part of this publication may be reproduced without prior permission of Muswell Hill Press www.muswellhillpress.co.uk British Library Cataloguing in Publication Data Sessa, Ben. The psychedelic renaissance : reassessing the role of psychedelic drugs in 21st century psychiatry and society. 1. Hallucinogenic drugs-Therapeutic use. 2. Hallucinogenic drugs-History. I. Title 615.7'883-d c23 ISBN-13: 9781 908995001 Printed in Great Britain by Marston Book Services This book is dedicated to my children Huxley, Kitty and Jimi. May your beloved pineal glands continue to secrete endogenous mystical compounds forever more, giving rise to a lifetime of spontaneous spiritual experiences. Contents Fo rewords by Rick Doblin and David Nutt ... ........................................ .. ...... xiii Introduction.......................................................................................................... 1 Apocalypse, Now and Then ........................................ ..... ...................... .......... I What Can the Psychedelics Offer Us? .............. ..... ........ .. ....... .. ......... ....... ... 2 Defining Psychedelic Drugs .... ......................................................
    [Show full text]
  • 11Th National Harm Reduction Conference November 3-6, 2016, San Diego, Ca
    11TH NATIONAL HARM REDUCTION CONFERENCE NOVEMBER 3-6, 2016, SAN DIEGO, CA THURSDAY, NOVEMBER 3, 2016 LOCATION: Grande Ballroom A/B 10:30 AM - 12:45 PM: Welcome Allan Clear, Office of Drug User Health, NYSDOH/AIDS Institute / New York, NY Monique Tula, Harm Reduction Coalition / Oakland, CA Opening Plenary Panel Harm Reduction that Heals the Most Harmed: A Call to Action Moderator: asha bandele is Drug Policy Alliance’s Senior Director of Grants, Partnerships and Special Projects and lives in New York City Panelists: ● Patrisse Cullors is an artist, organizer, freedom fighter, cofounder of Black Lives Matter, and lives in Los Angeles ● Crystal Lee, enrolled member of the Navajo Tribe, is a Postdoctoral Fellow at UCLA School of Medicine, Semel Institute for Neuroscience and Psychiatry and founder of United Natives. Crystal lives in Los Angeles and Las Vegas ● Tanagra María Melgarejo Pulido is an Adjunct Instructor at Universidad del Turabo and Permanent Housing Coordinator at Proyecto Matria in San Juan, Puerto Rico ● Deborah Small is a Public Health Fellow at Johns Hopkins University, founder of Break the Chains, and lives in the Bay Area 1:00 PM - 2:00 PM: Lunch (on your own) 2:15 PM - 3:45 PM: LOCATION: Grande Ballroom A PANEL: High-tech Harm Reduction ○ Using Text Messages to Engage People Living with HIV Who Also Use Drugs in Medical Care ■ Lara Coffin, HIV, ID and Global Medicine Division / UCSF, San Francisco, CA ○ The Effectiveness of Internet and Field Based Approaches to Recruit Young Adults who use Prescription Opioids Non-Medically:
    [Show full text]
  • Rave Parties
    U.S. Department of Justice Office of Community Oriented Policing Services Problem-Oriented Guides for Police Problem-Specific Guides Series No. 14 Rave Parties by Michael S. Scott www.cops.usdoj.gov Center for Problem-Oriented Policing Got a Problem? We’ve got answers! Log onto the Center for Problem-Oriented Policing website at www.popcenter.org for a wealth of information to help you deal more effectively with crime and disorder in your www.PopCenter.org community, including: • Web-enhanced versions of all currently available Guides • Interactive training exercises • On-line access to research and police practices Designed for police and those who work with them to address community problems, www.popcenter.org is a great resource in problem-oriented policing. Supported by the Office of Community Oriented Policing Services, U.S. Department of Justice. Problem-Oriented Guides for Police Problem-Specific Guides Series Guide No. 14 Rave Parties Michael S. Scott This project was supported by cooperative agreement #99­ CK-WX-K004 by the Office of Community Oriented Policing Services, U.S. Department of Justice. The opinions contained herein are those of the author(s) and do not necessarily represent the official position of the U.S. Department of Justice. www.cops.usdoj.gov ISBN: 1-932582-13-4 August 2004 About the Problem-Specific Guides Series i About the Problem-Specific Guides Series The Problem-Specific Guides summarize knowledge about how police can reduce the harm caused by specific crime and disorder problems. They are guides to prevention and to improving the overall response to incidents, not to investigating offenses or handling specific incidents.
    [Show full text]